RB1 and breast carcinoma: A direct comparison of an RB-deficient (HCC1937) and two RB-proficient (MCF7 and MDA-MB-231) epithelial breast cancer cell lines substantiated the close correlation between RB (S807/811) phosphorylation and origin licensing efficacy (Supplementary Fig. 5c).